SCHEMBL4279693

SCHEMBL4279693

CCCOc1ccc(Cc2c(O)cc(COC(C)=O)cc2F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 1/20 0.45
SLC5A2 P31639 1/20 0.45
LTA4H P09960 1/20 0.42
MAOB P27338 3/20 0.41
LMNA P02545 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAOA P21397 2/20 0.40
NAAA Q02083 1/20 0.39
ASAH1 Q13510 1/20 0.39
PLK1 P53350 1/20 0.39
ALDH1A1 P00352 2/20 0.38
ACACB O00763 1/20 0.37
IDH1 O75874 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
PDE4A P27815 1/20 0.37
HIF1A Q16665 1/20 0.37
HDAC10 Q969S8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4279412 0.91 MAPT (0.43) SLC5A1SLC5A2LTA4HMAOBLMNA
SCHEMBL4291912 0.86 NFKB1 (0.42) SLC5A1SLC5A2MAOBALDH1A1IDH1
SCHEMBL4286864 0.86 IDH1 (0.41) MAOBLMNAALDH1A1IDH1
SCHEMBL3998464 0.83 SLC5A1 (0.48) SLC5A1SLC5A2LTA4HLMNAL3MBTL1
SCHEMBL4286495 0.83 IDH1 (0.41) SLC5A1SLC5A2MAOBALDH1A1IDH1
SCHEMBL4285320 0.83 POLB (0.44) MAOBL3MBTL1MAOAALDH1A1IDH1
SCHEMBL4284273 0.82 SLC5A1 (0.47) SLC5A1SLC5A2LTA4HMAOBLMNA
SCHEMBL4289375 0.81 HTR2A (0.41) MAOBMAOANAAAALDH1A1ACACB
SCHEMBL4281303 0.79 SLC5A1 (0.40) SLC5A1SLC5A2LTA4HMAOBLMNA
SCHEMBL27774510 0.78 L3MBTL1 (0.57) SLC5A1SLC5A2LTA4HLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 SLC5A1 1/4885SLC5A2 2/4885LTA4H 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.